Bliss GVS Pharma

Last updated

Bliss GVS Pharma Limited
Type Public
BSE:  506197
NSE:  BLISSGVS
Industry Pharmaceuticals
Founded1984
Headquarters Mumbai, India
Area served
Worldwide
Key people
Mr. S. N. Kamath (Managing Director)
Products[Pharmaceuticals]
RevenueIncrease2.svg₹8,069.5 million (US$100 million) (2017-18) [1]
Increase2.svg₹886.7 million (US$11 million) (2017-18) [1]
Total assets Increase2.svg₹8,600.3 million (US$110 million) (2017-18) [1]
Total equity Increase2.svg₹5,362.4 million (US$67 million) (2017-18) [1]
Number of employees
666 [1]
Website www.blissgvs.com

Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others. [2] [3] [4]

Contents

As of 31 March 2018, its market capitalization is INR 19.20 billion (US$295 m). [1]

History

On 11 December 1984; Bliss GVS was incorporated as Bliss Chemicals and Pharmaceuticals India Limited. During its inception Bliss GVS Pharma operated as a public limited company. [5] In 1986, a vaginal contraceptive under the brand name "Today" was launched by the company which gradually rose to prominence in the Indian as well as the global market. [5]

On 9 May 2006, under the tenure of Mr. S.N. Kamath as the managing director, the board of directors approved the takeover of "Bliss Chemicals and Pharmaceuticals India Limited" by GVS Lab, causing a change of company's name to its current name "Bliss GVS Pharma Ltd." [5]

In the year 2007, along with the existing suppository manufacturing units, Bliss GVS commissioned for manufacturing units for Dry Syrups and Tablets. [5] The company marked its presence in the Middle-East pharmaceutical market through a strategic joint venture in the year 2012. [6] The Pessaries and Suppositories unit of Bliss GVS received an EU-GMP approval in the year 2011. [7]

The company marked its foray into the dermatology industry with its acquisition of a semi-solid manufacturing unit in 2012. Within the same year, the product range of Bliss GVS expanded with the setting up of Dry Powder manufacturing units for injections, along with other manufacturing units for Nasal Spray, Ampules and Eye/Ear/Nose Drops. [5] [8] [9]

In 2013, the R&D centre of Bliss GVS expanded to receive DSIR approval. [8]

The company opened its representative office in Philippines in the year 2014. [8] [10]

Operations

Bliss GVS has 5 manufacturing units and has presence in more than 60 countries. [9] Exports accounted for the majority of its revenues. [1] The manufacturing plants of Bliss GVS comply with the international standard on both local as well as the Global scale as per the cGMP norms. [11]

Products & Services

Among the African markets, Bliss GVS is touted as the segment leader for its range of Anti- Malarial products. Several of the brands owned by the company cover extensive range of combined formulations of Artemisinin. These Artemisinin formulations are provided through various dosage ranges including Suppositories and Injections, Tablets, Sachets and Suspensions. [10] [12]

Awards and recognition

For its performance in the exports sector, Bliss GVS received an award from the Indian Government in May 2014 for outstanding exports performance for the FY 2012–13. [12]

In December 2013, Bliss GVS was listed in Moneylife magazine's ‘Wealth Creators 2004-2013' list, an annual study of companies that have created the maximum wealth for investors over the past 10 years. [10] [11] [13]

In September 2011, Bliss GVS was awarded for its Outstanding Efforts in Research and Development by Government of India. [14]

In September 2010, Forbes included Bliss GVS in Asia's 200 Best under a billion. [15]

See also

Related Research Articles

Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and many other medical conditions.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Teva Pharmaceuticals</span> Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva Pharmaceuticals was the largest generic drug manufacturer, when it was surpassed briefly by US-based Pfizer. Teva regained its market leader position once Pfizer spun off its generic drug division in a merger with Mylan, forming the new company Viatris at the end of 2020. Overall, Teva is the 18th largest pharmaceutical company in the world.

<span class="mw-page-title-main">Beximco Pharma</span> Pharmaceutical company in Bangladesh

Beximco Pharmaceuticals Ltd also known as Beximco Pharma, is a pharmaceutical company in Bangladesh. It is a part of Bangladesh Export Import Company Limited (BEXIMCO).

<span class="mw-page-title-main">HLL Lifecare</span>

HLL Lifecare Limited (HLL) is an Indian healthcare product manufacturing company based in Thiruvananthapuram, Kerala, India. A Government of India-owned corporation.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin.

<span class="mw-page-title-main">Vivimed Labs</span>

Vivimed Labs Limited is an India-based global supplier of specialty chemicals and pharmaceuticals. Headquartered in Hyderabad, India. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Ajanta Pharma Limited, also known by the acronym APL, is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, South East Asia, West Asia, and CIS. It was established in 1973.

<span class="mw-page-title-main">Intas Pharmaceuticals</span> Indian multinational pharmaceutical company

Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 18 manufacturing plants, 15 in India and the rest in United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

<span class="mw-page-title-main">Cadila Pharmaceuticals</span> Indian pharmaceutical company

Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad, Gujarat, India. The company's operations focus on manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products and pharmaceutical Machinery.

Torque pharmaceuticals is an Indian pharmaceutical company with production units at Issapur, Derabassi in Punjab and at Jharmajri, Baddi in Himachal Pradesh. It manufactures medicines for prevention and treatment of various health related problems. The product range comprises antibiotics, nutritional supplements and cough syrup to antipyretics and anti-inflammatory products.

Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

<span class="mw-page-title-main">Laurus Labs</span> Indian pharmaceutical company

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology. veterinary APIs and agro chemicals. The company was founded in 2005 by Dr. Satyanarayana Chava.

<span class="mw-page-title-main">Panaxia</span> Israeli medical cannibis company

Panaxia Pharmaceutical Industries Ltd. is a global company headquartered in Israel, that develops, manufactures and markets medical cannabis-based products in pharmaceutical quality. The company has commercial activity in Germany, France, Cyprus and Malta.

References

  1. 1 2 3 4 5 6 7 "Quarterly report 2017-18". Bliss GVS.
  2. ↑ "The Brand Manufacturing of Bliss GVS Labs".
  3. ↑ "Uninterested but worth a look". Archived from the original on 3 September 2014. Retrieved 3 September 2014.
  4. ↑ "The products manufactured and marketed by Bliss GVS".
  5. 1 2 3 4 5 "Money Control".
  6. ↑ "NSE India and Bliss GVS" (PDF).
  7. ↑ "Manufacturing Locations of Bliss GVS".
  8. 1 2 3 "Timeline History of Bliss GVS".
  9. 1 2 "Bliss GVS Pharma buys 70% stake in Skincare Products".
  10. 1 2 3 "Bliss GVS Chairman's Speech - Economic Times".
  11. 1 2 "The Latest Trending News about Bliss GVS". Archived from the original on 3 September 2014. Retrieved 3 September 2014.
  12. 1 2 "Brand Manufacturing of Bliss GVS Labs - Economic Times".
  13. ↑ "Wealth Creators 2004-2013: Which Indian companies have generated the maximum wealth?".
  14. ↑ "Bliss GVS Pharma Updates".
  15. ↑ "Asia's 200 Best Under A Billion". Forbes .
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.